Enrollment in Medicaid helps lower-income Americans overcome depression, get proper treatment for diabetes, and avoid catastrophic medical bills, but it does not appear to reduce the near-term prevalence of diabetes, high blood pressure, or high cholesterol, according to a new study coauthored by MIT economist Amy Finkelstein.
The study, a randomized evaluation comparing health outcomes among more than 12,000 people in Oregon, employs the same approach as a clinical trial. Its findings bear on the implementation of the federal government’s Affordable Care Act, which gives funding to states to expand Medicaid, the program administered jointly by the federal government and the states to provide health insurance for (mostly) low-income U.S. citizens. A paper based on the research appeared in the New England Journal of Medicine in May.
The researchers worked with the Oregon Health Study Group to analyze Medicaid’s impact over a two-year span. They found about a 30 percent decline in the rate of depression among people on Medicaid over that time, thanks to treatment; an increased probability of being diagnosed with, and treated for, diabetes; and increases in use of preventive care. They also found that Medicaid reduced, by about 80 percent, the chance of having catastrophic out-of-pocket medical expenses, defined as spending 30 percent of one’s annual income on health care.
“That’s important, because from an economics point of view, the purpose of health insurance is to … protect you financially,” says Finkelstein. She and Katherine Baicker of Harvard University’s School of Public Health led the study.
The researchers did not find any change in three other health measures: blood pressure, cholesterol, and a common indicator of diabetes. However, Baicker notes that Medicaid increased the use of services such as mammograms, cholesterol screening, doctor’s office visits, and prescription drugs.
The study uses data from a unique lottery program the state of Oregon founded in 2008, in which about 90,000 people applied for roughly 10,000 newly available slots to gain Medicaid coverage. That lottery generated a group of residents covered by Medicaid who were otherwise similar to a control group of applicants still lacking coverage.
“We recognized the lottery as a literally once-in-a-lifetime opportunity to bring the rigors of a randomized controlled trial, which is the gold standard in medical and scientific research, to one of the most pressing social policy questions of our day,” Finkelstein says.
Forget dating apps: Here’s how the net’s newest matchmakers help you find love
Fed up with apps, people looking for romance are finding inspiration on Twitter, TikTok—and even email newsletters.
How AI is reinventing what computers are
Three key ways artificial intelligence is changing what it means to compute.
These weird virtual creatures evolve their bodies to solve problems
They show how intelligence and body plans are closely linked—and could unlock AI for robots.
We reviewed three at-home covid tests. The results were mixed.
Over-the-counter coronavirus tests are finally available in the US. Some are more accurate and easier to use than others.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.